The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
Brian J Linder - One of the best experts on this subject based on the ideXlab platform.
-
robot assisted vesicovaginal fistula repair via a transvesical approach
International Urogynecology Journal, 2019Co-Authors: John A Occhino, Erik D Hokenstad, Brian J LinderAbstract:Objective The objective of this video is to demonstrate a technique for robot-assisted vesicovaginal fistula (VVF) repair utilizing a mini Cystotomy with a transvesical approach.
Arup K Mandal - One of the best experts on this subject based on the ideXlab platform.
-
robot assisted vesicovaginal fistula repair a safe and feasible technique
International Urogynecology Journal, 2017Co-Authors: Girdhar S Bora, Santosh Kumar, S Singh, Ravimohan S Mavuduru, Sudheer K Devana, Uttam Mete, Shrawan Kumar Singh, Arup K MandalAbstract:Introduction and hypothesis Open transabdominal repair of vesicovaginal fistula (VVF) requires a long Cystotomy incision, suprapubic drainage and delayed recovery. Laparoscopic repair is limited by difficult suturing in pelvic procedures. Therefore, the utility of robotic assistance is being increasingly explored. We share our initial experience of robot-assisted laparoscopic VVF repair.
John A Occhino - One of the best experts on this subject based on the ideXlab platform.
-
robot assisted vesicovaginal fistula repair via a transvesical approach
International Urogynecology Journal, 2019Co-Authors: John A Occhino, Erik D Hokenstad, Brian J LinderAbstract:Objective The objective of this video is to demonstrate a technique for robot-assisted vesicovaginal fistula (VVF) repair utilizing a mini Cystotomy with a transvesical approach.
Y Hashimoto - One of the best experts on this subject based on the ideXlab platform.
-
six month postoperative outcomes of intraoperative oct guided surgical Cystotomy for refractory cystoid macular edema in diabetic eyes
Clinical Ophthalmology, 2017Co-Authors: Yuichi Asahina, N Tachi, Yumi Asahina, Kayoko Yoshimura, Yoshiki Ueta, Y HashimotoAbstract:Purpose This study evaluated the outcomes of surgical Cystotomy for recurrent diabetic cystoid macular edema (CME). Patients and methods We analyzed 20 eyes with a clinical diagnosis of diabetic retinopathy and refractory CME. Release of vitreoretinal adhesion, epiretinal membrane (ERM) and internal limiting membrane (ILM) peeling and Cystotomy guided by intraoperative optical coherence tomography (iOCT) were performed in every patient. Pars plana vitrectomy was also performed in 17 patients, 11 of whom also underwent lensectomy and intraocular lens implantation. Central retinal thickness (CRT), central minimum macular thickness (CMMT), macular volume (MV) and best-corrected visual acuity (BCVA) were compared preoperatively and 1 and 6 months post surgery. Results CRT, CMMT and MV significantly improved 1 and 6 months post surgery in each group (P<0.01). Significant improvements in BCVA were only observed 6 months post surgery (P<0.01). No intra- or postoperative complications were observed in all patients. Conclusion CRT, CMMT, MV and BCVA significantly improved 6 months following surgical cystectomy. This implies that iOCT-guided Cystotomy could be another treatment option for refractory CME in diabetic eyes.
-
Cystotomy for diabetic cystoid macular edema.
Documenta ophthalmologica. Advances in ophthalmology, 1999Co-Authors: N Tachi, Y Hashimoto, N OginoAbstract:The purpose of this study was to evaluate the role of vitrectomy with Cystotomy in the treatment of diabetic cystoid macular edema (CME). Among 22 eyes of 21 patients with diabetic CME underwent phacoemulsification, intraocular lens implantation, pars plana vitrectomy, induction of posterior vitreous detachment, and Cystotomy or cystectomy. Follow-up ranged from 3 to 29 months. Under biomicroscopic examination, Cystoid macular edema was eliminated in 16 of 22 eyes during the follow-up period. Ring-shaped residual edema was observed in one eye. Corrected visual acuity improved in 7 of 22 eyes by more than one Snellen line (P = 0.0391, paired t-test), remained the same in 13 eyes, and decreased by more than one line in 2 eyes. This pilot study shows that Cystotomy may have a role in the treatment of cystoid macular edema in diabetic patients.
Makoto Nakamura - One of the best experts on this subject based on the ideXlab platform.
-
Cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to branch retinal vein occlusion
Scientific Reports, 2021Co-Authors: Hiroko Yamada, Hisanori Imai, Akira Tetsumoto, Mayuka Hayashida, Keiko Otsuka, Akiko Miki, Sentaro Kusuhara, Makoto NakamuraAbstract:To demonstrate the long-term effect of Cystotomy with or without fibrinogen clot removal for treatment-resistant cystoid macular edema (CME) secondary to branch retinal vein occlusion (BRVO). Retrospective clinical study. We retrospectively analyzed medical records of 22 eyes of 22 patients with treatment-resistant CME secondary to BRVO with 12 months observation after Cystotomy with or without fibrinogen clot removal. Patients included 11 women and 11 men. The mean ± SD age was 72.7 ± 10.2 years. LogMAR-converted best corrected visual acuity (BCVA) was statistically better at 12 months after surgery (0.30 ± 0.30) than preoperative BCVA (0.39 ± 0.27) (p = 0.01). The central sensitivity of microperimetry (dB) was maintained during follow-up (preoperative sensitivity: 25.4 ± 4.1, postoperative sensitivity at 12 months after the surgery: 25.9 ± 4.2, p = 0.69). Twelve months after surgery, there was a significant improvement in the central retinal thickness (CRT) on optical coherence tomography (OCT) (303.7 ± 80.1) (μm) compared with the preoperative CRT (524.2 ± 114.8) (p < 0.01). In 12 months, CME recurred in 3 of 22 eyes. The preoperative reflectivity in cystoid cavity on OCT was significantly higher in patients with fibrinogen clot removal (n = 5) than in patients without fibrinogen clot removal (n = 17) (p < 0.01). For treatment-resistant CME secondary to BRVO, Cystotomy with or without fibrinogen clot removal may be one of the treatment options.
-
the long term effect of Cystotomy with fibrinogen clot removal for a cystoid macular edema secondary to idiopathic macular telangiectasia type 1 a case report
Retinal Cases & Brief Reports, 2021Co-Authors: Hitomi Maki, Hisanori Imai, Hiroko Yamada, Akira Tetsumoto, Mayuka Hayashida, Keiko Otsuka, Akiko Miki, Makoto NakamuraAbstract:Purpose To report the case of a patient with cystoid macular edema (CME) secondary to idiopathic macular telangiectasia (MacTel) type 1, which was successfully treated by Cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion. Patients A 80-year-old man was referred to our department because of a visual defect in his right eye. His best corrected decimal visual acuity (BCVA) was 0.7 (Snellen equivalent [SE], 20/30). Methods A fundus examination revealed clustered temporal juxafoveal microaneurysms and foveal CME. The patient refused to undergo conventional treatments, including direct retinal photocoagulation for microaneurysms, intravitreal anti-vascular endothelial growth factor injection, and intravitreal triamcinolone injection. However, he provided consent to undergo Cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion. Results His BCVA was 0.2 (SE, 20/100) just before the surgery. A 27-gauge vitrectomy with internal limiting membrane peeling was performed. Cystotomy was performed during the surgery, and the fibrinogen clot visible in the cystoid cavity was also removed. CME rapidly disappeared after the surgery. Three years postoperatively, the patient had BCVA of 0.5 (SE, 20/40) at the last medical examination, and the CME had not recurred. Conclusion Cystotomy and en bloc removal of the fibrinogen-rich component of the cystoid lesion could be valid treatment options for CME secondary to MacTel type 1.
